Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
1 FDA-approved treatment is available for isolated bone marrow mastocytosis, including CROMOLYN SODIUM (GASTROCROM, approved 1996).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
No clinical trials have been registered for isolated bone marrow mastocytosis.
3 publications have been identified in PubMed for isolated bone marrow mastocytosis. Research spans Case Report / Case Series (67%) and Review / Meta-Analysis (33%).
Estublier B (2026). [PMID: 41379048](https://pubmed.ncbi.nlm.nih.gov/41379048/). *JACC. Case reports*. [Case Report / Case Series]
Rajendram R (2025). [PMID: 39557214](https://pubmed.ncbi.nlm.nih.gov/39557214/). *Clinical medicine (London, England)*. [Case Report / Case Series]
Bulai Livideanu C (2025). [PMID: 41039576](https://pubmed.ncbi.nlm.nih.gov/41039576/). *Orphanet journal of rare diseases*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
GASTROCROM
CROMOLYN SODIUM |
— |
1996 |
Available |
View trials for isolated bone marrow mastocytosis